Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial.
about
Prophylactic vaccinations in chronic kidney disease: Current statusInfluenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort studyThe antibody response to pandemic H1N1 2009 influenza vaccine in adult organ transplant patients.Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals.Pre- and post-pandemic prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in Austrian adults.Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.Immunogenicity of low-dose MF59-adjuvanted 2009 influenza A/H1N1 vaccine in dialysis patients.Risk factors affecting seroconversion after influenza A/H1N1 vaccination in hemodialysis patients.Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment.Cost-effectiveness of adjuvanted versus nonadjuvanted influenza vaccine in adult hemodialysis patientsChanges of immunogenic profiles between a single dose and one booster influenza vaccination in hemodialysis patients - an 18-week, open-label trialImmunization in end-stage renal disease: opportunity to improve outcomes.Influenza vaccination in patients with end-stage renal disease.The role of age-related T-cell differentiation in patients with renal replacement therapy.Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma.Adjuvanted influenza vaccines
P2860
Q26827388-0F788A06-5C3F-4B0E-8601-C45B7D978B91Q30407134-899063C9-5BC2-4CAA-86AF-971BE7EB1001Q30409959-2685FC9C-5637-4576-AB89-53B01AF560C5Q30413293-EA5376A9-BF97-4164-ABB6-F1237FA8CA4AQ30417245-EFBFB70B-89A6-48B5-B462-ECABE1D6B1CAQ30419575-D8688F6B-B577-48F2-9F92-5E316A313A61Q30420230-D0E98FD8-F416-40CF-B614-17A1B77B5823Q30421428-FD42D141-9167-4DDC-9886-D51C0587739DQ30424358-F2A1F9B0-2EBC-4FBA-9F95-066F68F109B9Q33847653-D90F51AC-4303-4223-B2D5-E77DCB7E49EAQ34903425-B89477D0-B44F-43D1-BF56-6D84A2509F91Q36574698-79EECDF7-633C-457D-8C2F-B58FD0FC2C55Q38113298-F7A57348-D2FD-48D7-AB1D-6D92047C2A1AQ38516153-6469BFE6-D8DF-4A33-A1D0-E7F81B1C283EQ38672633-401D41E5-8A0B-462A-A023-6D1A0A98B821Q42384494-E9ADE8ED-872A-4E57-A5E4-5CF3D07F4A63Q57094841-B7B56D91-968F-4283-BD12-2AB2F7FEA865
P2860
Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Immunogenicity and efficacy in ...... (H1N1): a nonrandomized trial.
@ast
Immunogenicity and efficacy in ...... (H1N1): a nonrandomized trial.
@en
type
label
Immunogenicity and efficacy in ...... (H1N1): a nonrandomized trial.
@ast
Immunogenicity and efficacy in ...... (H1N1): a nonrandomized trial.
@en
prefLabel
Immunogenicity and efficacy in ...... (H1N1): a nonrandomized trial.
@ast
Immunogenicity and efficacy in ...... (H1N1): a nonrandomized trial.
@en
P2093
P1476
Immunogenicity and efficacy in ...... (H1N1): a nonrandomized trial.
@en
P2093
Claudia Sommerer
Dorothea Ksoll-Rudek
Heidrun Hampel
Martin Zeier
Paul Schnitzler
Ralf Dikow
Vedat Schwenger
P304
P356
10.1053/J.AJKD.2010.11.031
P577
2011-02-23T00:00:00Z